|
Regency/Columbia Foyer & Columbia A-B
| |||
R2: Poster Session #2 | |||
100 | Hepatitis B Vaccine Coverage among Adults Tested for HIV in the United States Kaafee Billah, Cindy Weinbaum, Anthony Fiore, Lyn Finelli, D. Hurst, Shannon Stokley | ||
101 | DEBI-Izing an Oregon Harm Reduction Program Targeting HIV and HCV Prevention among People who Inject Drugs Ann Shindo | ||
102 | A Review of Hepatitis Infection in Pakistan Altaf Bosan | ||
103 | Hepatitis C Risk Behaviors among STD Clinic Clients in Upstate New York Elena M. Rizzo, Marilyn A. Kacica, Lindsay Ward, Martha Newcomb, Elizabeth Herlihy, Colleen Flanigan | ||
104 | Hepatitis A and Hepatitis B Vaccination in High Risk Adults: Florida’s Experience With Integrating Services Susanne R. Crowe, Sandra W. Roush | ||
105 | Evaluation of the Florida Hepatitis and Liver Failure Prevention and Control Program Susanne R. Crowe, Sandra W. Roush, Jacquie Rainey | ||
106 | Receipt of Follow-up Services among Persons with Confirmed Positive Hepatitis C Virus Test Results: Wisconsin, 2004 Marjorie Hurie, Pamela Rogers, Neil Hoxie | ||
107 | The benfits of referring Acute Hepatitis C Clients into Prevention Case Management Programs Lois Carnicom, Cheryl V. Pearcy | ||
108 | Hepatitis Prevention Practices for Women in Prostitution Patti A. Buffington | ||
109 | HCV Testing Pilot: State of Connecticut Department of Public Health Laboratory and Viral Hepatitis Program Partnership Andrea Lombard | ||
110 | HCV Outbreak at an Oncology Clinic in Fremont Nebraska Kathryn L. White | ||
111 | Hepatitis B Vaccination Proximate to Syringe Exchange Sites Frederick L. Altice, Robert D. Bruce, Mary Walton, Marta Buitrago | ||
112 | Testing and Counseling for Hepatitis B, Hepatitis C, and HIV Infections in Opioid Treatment Programs (OTP’s). Summary results from two surveys Thomas F. Kresina, Carleen Maxwell, Mark W. Parrino, Robert Lubran | ||
113 | The Gold Standard of Safer Injection: A Hepatitis Preventative Injection: Gregory Scott, Dan Bigg | ||
114 | Screening for Viral Infections (HIV, HBV, HCV) Among IDUs through the BEAT Program: Buprenorphine Easy Access to Treatment Robert D. Bruce, Jason Farrell | ||
115 | Hepatitis Prevention for Drug Users in Switzerland Rudolf Hotz | ||
116 | Sexual and drug-injecting behaviors among persons with HIV infection related to injection drug use—results from an interview project, 2000-2003 Andrew J. Mitsch, John E. Gerstle, Michael L. Campsmith, M. Kathleen Glynn, Glenn V. Nakamura | ||
117 | Cost-Effectiveness of Testing Strategies for Chronic Hepatitis C Michael K. Chapko, Kevin L. Sloan, John W. Davison, Jason A. Dominitz | ||
118 | Hepatitis A Infection in Injection Drug Users and Homeless Persons in Massachusetts: Responding to an Outbreak Erica Berl, Daniel Church | ||
119 | Preliminary Results from a Hepatitis Vaccine Program Targeted to Injection Drug Users Lauretta E. Grau, Erin Curtin, Huije He, Merrill Singer, Robin Clark-Smith, Gregory Scott, Robert Heimer | ||
120 | Prevention of Hepatitis B in a Correctional System Lester N. Wright | ||
121 | Integration Across Jurisdictions: Enhanced Screening in a Rural AI/AN Population Cecile M. Town, Alexander White Tail Feather, John T. Redd | ||
122 | Integration in the Alaskan Bush: Use of Community Health Aides to Deliver Hepatitis, STD and HIV Services Kathleen A. Cunniffe, Walter Palkovitch, Julie Klaker, Cecile M. Town, John T. Redd | ||
123 | Evaluation of Targeted Hepatitis C Virus Screening of Inmates Admitted in 2004 to the Wisconsin Adult Correctional System Gerald Gabor, John R. Pfister, Marjorie Hurie, James Greer, Patricia Voermans, Brent Haase, David Burnett, Jeffrey P. Davis | ||
124 | How to Work With Your State Legislature Diane Peterson | ||
125 | Hepatitis Prevention, Testing and Treatment in a Rural Health Center Janet L. Soule, John Carrington | ||
126 | Challenges to Treatment of Hepatitis C in a Community Methadone Clinic Kenneth T. Akinaka, Alan D. Tice, Mark Herrington | ||
127 | The Ribavirin Pregnancy Registry (RPR) is Established Susan Sinclair Roberts, The Ribavirin Pregnancy Registry Scientific Advisory Board | ||
128 | Perspectives on hepatitis C virus epidemiology in drug users Holly Hagan | ||
129 | Viral Hepatitis C Integration Program Rodney S. Gaither | ||
130 | Integrating Perinatal Hepatitis C Prevention Activities into Perinatal Hepatitis B Prevention Programs Patricia Raymond-Mangan, Silvia Degli-Esposti, Sue Ferreira | ||
131 | A Syringe Exchange-Based Hepatitis Prevention Campaign for Injection Drug Users in Three U.S. Cities Lauretta E. Grau, Patricia A. Marshall, Merrill Singer, Ricky N. Bluthenthal, Robert Heimer | ||
132 | North Dakota Prisons Division Hepatitis Program Kathleen M. Bachmeier, Kent Martin, John J. Hagan, Jeffrey E. Hostetter, Olimpia Rauta | ||
133 | Building partnerships to provide prevention services in IDU populations Alissa Fountain, Cheri D. Reyes | ||
134 | HCV Risk Assessment and Screening in the Primary Care Office Steven E. Szebenyi, Colleen A. Flanigan, Marilyn A Kacica, Susan Gieryic, Shadi Saleh, Carin Upstill | ||
135 | Sexual Transmission of Hepatitis C Virus (HCV) among Drug Users: A Systematic Review, 1995-2004 Salaam Semaan, Kimberly Workowski, Don Des Jarlais | ||
136 | Hepatitis B and Hepatitis C Coinfection with HIV/AIDS in Chicago, Illinois Alicia M. Siston, Alexandra M. Gagner, Donna Peace, Damien Christiansen, Nanette Benbow, Susan I. Gerber | ||
137 | A Pilot Project to Provide Hepatitis B Vaccine to Adults in the Public Health STD Clinic Setting Julie S. Townsend, Lisa Davis, Jim Lee, Rita R. Espinoza | ||
138 | Prevention of Hepatitis B Virus (HBV) among Injection and Non-Injection Drug users: A Systematic Review, 1995-2004 Salaam Semaan, Kimberly Workowski, Don C. Des Jarlais | ||
139 | Hepatitis C Seroconversion is Still Occurring in Veterans Kevin L. Sloan, Michael K. Chapko, Meaghan F. Splan, Jason A. Dominitz | ||
140 | Lessons Learned from a Comparison of Hepatitis Pre-Screening Protocols in Three Multiple Morbidity Mobile Testing Programs Jenny Gross | ||
141 | Hepatitis C Virus Infection: Survey of Screening, Evaluation & Treatment Practices Louis Katz, Rebecca J. Heick, Roma Taylor | ||
142 | Hepatitis Integration into Substance Abuse Treatment, Multiple Level Interventions Corinna Dan | ||
143 | Not Just the Needles: Social Networks, Social Marketing, and Serostatus in HCV Prevention for IDUs Daniel Raymond | ||
144 | HCV Knowledge and Self Efficacy among Drug Treatment Program Staff Shiela Strauss, Janetta Astone-Twerell, Corrine Munoz-Plaza, Don Des Jarlais, Marya Gwadz, Holly Hagan, Andrew Osborne, Andrew Rosenblum | ||
145 | Community Partners Logic Model Julie Gleason-Comstock, Harry L. Simpson |
The 2005 National Viral Hepatitis Prevention Conference of CDC